The glucose level that defines diabetes mellitus is that level above w
hich patients have a high risk of eye, kidney, and neuronal disease. T
he risk of these complications rises as glucose levels increase, and d
ecreases as therapy brings the glucose level down. Thus, in patients w
ith diabetes, glucose is a continuous, modifiable risk factor for eye,
kidney and peripheral nerve disease. Plasma glucose concentrations in
the diabetic range are also a continuous risk factor for cardiovascul
ar disease (CVD). Moreover, epidemiological evidence shows that the re
lationship between plasma glucose concentration and CVD extends well b
elow the glucose level defined for diabetes and even impaired glucose
tolerance. This continuous relationship between glucose and CVD exists
in all people, not just in those with a defined metabolic disease, an
d is therefore similar to the relationship between cholesterol or bloo
d pressure and CVD. It may be secondary to either a direct effect of e
levated glucose or to some underlying metabolic abnormality that raise
s both glucose and cardiovascular risk. Whether interventions that low
er glucose will also lower the risk of CVD is still unknown; the resul
ts of clinical trials are awaited. (C) 1997 by John Wiley & Sons, Ltd.